Nextiva (www.nextiva.com), an industry-leading cloud-based communications provider, announced today that its philanthropic branch, Nextiva Cares, gifted $100,000 to the Barrow Brain Tumor Research Center in partnership with The Gorny Foundation.
The $100,000 gift will go towards advancing the research and development of new treatments and studies that will enhance our knowledge of brain health and enable the Barrow Neurological Institute team to assist patients in new and effective ways.
Nearly 140,000 Americans are fighting a malignant brain tumor right now. In a bold effort to find cutting-edge solutions to this statistic, the Barrow Brain Tumor Research Center works diligently to develop groundbreaking treatments and studies, like the Phase 0/2 clinical trial.
Phase 0/2 is currently the quickest route to identifying effective treatment options to battle glioblastoma, the most common type of brain tumor. More than 9 out of 10 people with glioblastoma will live less than five years after their diagnosis. In Phase 0, patients with a recurrent glioblastoma tumor are administered a small dose of a drug judged promising for their cancer. Within hours of the initial treatment, neurosurgeons remove the tumor and determine if the experimental drug reached the tumor and affected its biology. If the drug was effective, the patient will move directly into Phase 2 and continue taking it, often as one of the first brain tumor patients in the world to be treated with the experimental drug; if not, they can move on to other therapies without losing much time.
“The support from The Gorny Foundation and Nextiva Cares will allow our dedicated team to move forward with revolutionary trials and treatments, with the goal of identifying a cure for glioblastoma in the next 10 years,” said Katie Cobb, President of Barrow Neurological Foundation.
“Barrow Brain Tumor Research Center’s team takes an admirable and forward-thinking approach to brain health. As they work to create innovative solutions like Phase 0/2, our understanding of brain cancer and treatments will take us closer to a cure,” said Tomas Gorny, who is a member of the Barrow Neurological Foundation Board of Trustees. “We’re honored to support an organization that makes such a difference in our community.”
About The Gorny Foundation and Nextiva Cares
Founded by Tomas and Aviva Gorny, The Gorny Foundation is committed to supporting programs that make a difference today and leave a lasting impact for generations to come. The Gornys actively participate in the causes they’re involved in on a local and global level.
Nextiva Cares is the community advocacy and philanthropic initiative of Nextiva, a leading business communications provider, focused on supporting charity organizations that help our local community.
About Barrow Neurological Foundation
Barrow Neurological Foundation raises awareness and funding for patient care, medical education, and research offered at Barrow Neurological Institute. Barrow is an internationally-recognized leader in neurology, neurosurgery and neuroscience research, treating patients with a wide range of conditions, including brain and spinal tumors, concussion and brain and spinal traumas, neuromuscular diseases, stroke, cleft and craniofacial disorders, and cerebrovascular disorders. SupportBarrow.org
Nextiva is an innovative tech company dedicated to simplifying business communications, team collaboration, and customer engagement. NextOS powers its solutions, including business phone service, CRM, analytics, chat, and surveys. Founded in 2008 on the principle of Amazing Service, Nextiva serves more than 150,000 businesses nationwide, and employs over 1,000 team members. Learn more at www.nextiva.com.
Speak Your Mind
You must be logged in to post a comment.